These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8296736)

  • 1. Frequency of inclusion of patients with cardiogenic shock in trials of thrombolytic therapy.
    Col NF; Gurwitz JH; Alpert JS; Goldberg RJ
    Am J Cardiol; 1994 Jan; 73(2):149-57. PubMed ID: 8296736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolytic therapy in cardiogenic shock: effect of increased aortic pressure and rapid tPA administration.
    Garber PJ; Mathieson AL; Ducas J; Patton JN; Geddes JS; Prewitt RM
    Can J Cardiol; 1995 Jan; 11(1):30-6. PubMed ID: 7850662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multidisciplinary approach to the treatment of cardiogenic shock].
    Nadziakiewicz P; Knapik P; Gasior M; Kalarus Z; Poloński L; Zembala M
    Kardiol Pol; 2007 Jan; 65(1):105-9. PubMed ID: 17295171
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemodynamic, mechanical, and metabolic determinants of thrombolytic efficacy: a theoretic framework for assessing the limitations of thrombolysis in patients with cardiogenic shock.
    Becker RC
    Am Heart J; 1993 Mar; 125(3):919-29. PubMed ID: 8438733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The exclusion of the elderly and women from clinical trials in acute myocardial infarction.
    Gurwitz JH; Col NF; Avorn J
    JAMA; 1992 Sep; 268(11):1417-22. PubMed ID: 1512909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock.
    Unverzagt S; Machemer MT; Solms A; Thiele H; Burkhoff D; Seyfarth M; de Waha A; Ohman EM; Buerke M; Haerting J; Werdan K; Prondzinsky R
    Cochrane Database Syst Rev; 2011 Jul; (7):CD007398. PubMed ID: 21735410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of patients with acute myocardial infarction for thrombolytic therapy.
    Muller DW; Topol EJ
    Ann Intern Med; 1990 Dec; 113(12):949-60. PubMed ID: 2240919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolytic therapy in patients where hypotension or cardiogenic shock complicate acute myocardial infarction.
    Prewitt RM
    Can J Cardiol; 1993 Mar; 9(2):155-7. PubMed ID: 8490783
    [No Abstract]   [Full Text] [Related]  

  • 9. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary coronary angioplasty versus thrombolysis for acute myocardial infarction.
    French JK; Canborn TA; Sleeper LA
    Lancet; 2003 Apr; 361(9365):1303-4; author reply 1304-5. PubMed ID: 12699988
    [No Abstract]   [Full Text] [Related]  

  • 11. Changing practice patterns in the management of acute myocardial infarction complicated by cardiogenic shock: elderly compared with younger patients.
    Dzavík V; Burton JR; Kee C; Teo KK; Ignaszewski A; Lucas AR; Tymchak WJ
    Can J Cardiol; 1998 Jul; 14(7):923-30. PubMed ID: 9706277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of progress in cardiogenic shock: lessons from the GUSTO trials.
    Menon V; Hochman JS; Stebbins A; Pfisterer M; Col J; Anderson RD; Hasdai D; Holmes DR; Bates ER; Topol EJ; Califf RM; Ohman EM
    Eur Heart J; 2000 Dec; 21(23):1928-36. PubMed ID: 11071798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the evidence for IABP in STEMI with and without cardiogenic shock?
    de Waha S; Desch S; Eitel I; Fuernau G; Lurz P; de Waha A; Schuler G; Thiele H
    Ther Adv Cardiovasc Dis; 2012 Jun; 6(3):123-32. PubMed ID: 22569335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiogenic shock complicating acute myocardial infarction; prognostic impact of early and late shock development.
    Lindholm MG; Køber L; Boesgaard S; Torp-Pedersen C; Aldershvile J;
    Eur Heart J; 2003 Feb; 24(3):258-65. PubMed ID: 12590903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome.
    Unverzagt S; Wachsmuth L; Hirsch K; Thiele H; Buerke M; Haerting J; Werdan K; Prondzinsky R
    Cochrane Database Syst Rev; 2014 Jan; (1):CD009669. PubMed ID: 24385385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-hospital mortality of patients with cardiogenic shock after acute myocardial infarction; impact of early revascularization.
    Hashmi KA; Abbas K; Hashmi AA; Irfan M; Edhi MM; Ali N; Khan A
    BMC Res Notes; 2018 Oct; 11(1):721. PubMed ID: 30309379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions in acute myocardial infarction.
    Dixon SR; O'Neill WW
    Curr Probl Cardiol; 2001 Oct; 26(10):619-72. PubMed ID: 11641649
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of clinical trials on clinical practice: example of thrombolysis for acute myocardial infarction.
    Ketley D; Woods KL
    Lancet; 1993 Oct; 342(8876):891-4. PubMed ID: 8105166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.
    Hochman JS; Sleeper LA; Webb JG; Sanborn TA; White HD; Talley JD; Buller CE; Jacobs AK; Slater JN; Col J; McKinlay SM; LeJemtel TH
    N Engl J Med; 1999 Aug; 341(9):625-34. PubMed ID: 10460813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiogenic shock.
    Moscucci M; Bates ER
    Cardiol Clin; 1995 Aug; 13(3):391-406. PubMed ID: 7585775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.